Skip to content

Bill Sanders

4 papers in the library · publishing 2006-2008

Papers

Sort Most recent Most cited

"Research chemicals": tryptamine and phenethylamine use among high-risk youth.

Substance Use & Misuse 2008 Bill Sanders, Stephen E Lankenau, Jennifer Jackson Bloom et al.

Tryptamines and phenethylamines are two broad categories of psychoactive substances with a long history of licit and illicit use. Profiles of users of recently emerging tryptamines and phenethylamines are nonexistent, however, since surveillance studies do not query the use of these substances. This manuscript describes the types, modes of administration, onset of use, and context of use of a...

Towards an Explanation of Subjective Ketamine Experiences among Young Injection Drug Users.

Addiction Research & Theory 2008 Stephen E Lankenau, Bill Sanders, Jennifer Jackson Bloom et al.

Ketamine is a dissociative anesthetic with powerful sedative and hallucinogenic properties. Despite the wide variability in reported subjective experiences, no study has attempted to describe the particular factors that shape these experiences. This manuscript is based upon a sample of 213 young injection drug users recruited in New York, New Orleans, and Los Angeles with histories of ketamine...

Patterns of ketamine use among young injection drug users.

Journal of Psychoactive Drugs March 2007 Stephen E Lankenau, Bill Sanders

Ketamine is a dissociative anesthetic that has emerged as an increasingly popular choice among young drug users. Recent research indicates the presence of hidden populations of young people who inject ketamine in New York and other U.S. cities. Applying an ethno-epidemiological approach, the authors recruited 40 young injection drug users (IDUs) (< 25 years old) in New York City to explore...

First injection of ketamine among young injection drug users (IDUs) in three U.S. cities.

Drug and Alcohol Dependence September 18, 2006 Stephen E Lankenau, Bill Sanders, Jennifer Jackson Bloom et al.

Ketamine, a dissociative anesthetic, has emerged as an increasingly common drug among subgroups of young injection drug users (IDUs) in cities across the United States. In-depth qualitative interviews were conducted with 213 young IDUs aged 16-28 years recruited in New York, New Orleans, and Los Angeles between 2004 and 2006. While some initiated injection drug use with ketamine, the drug was...

DOI: 10.1016/j.drugalcdep.2006.08.015 (opens in new tab) Full text (opens in new tab) Ketamine Humans Substance-related disorders Substance abuse, intravenous +14